Before a new vaccine is approved for release on the market, a rigorous regulatory procedure to assess these steps should be undertaken:

Question

Before a new vaccine is approved for release on the market, a rigorous regulatory procedure to assess these steps should be undertaken:

BlackTom AI · Accepted Answer

Question restatement: Before a new vaccine is approved for release on the market, a rigorous regulatory procedure to assess these steps should be undertaken:

Answer options: 
- Safety.
- Efficacy.
- Quality
- All of the above.

Option 1: 'Safety.' Regulatory review certainly includes safety assessment to ensure the vaccine does not pose unacceptable risks to recipients, evaluating adverse events, reactogenicity, and overall risk/benefit balance. However, focusing only on safety omits other essential dimensions that regulators consider.

Option 2: 'Efficacy.' Demonstrating that the vaccine provides the intended protective effect under defined conditions is crucial. Efficacy data from well-designed trials inform whether the vaccine actually prevents disease in the target population. Yet, efficacy assessment alone does not address how the product is manufactured or whether the benefits outweigh potential harms.

Option 3: 'Quality.' Quality assessment covers the manufacturing process, product consistency, stability, and purity. This ensures the vaccine is produced to predefined specifications and remains safe and effective throughout its shelf life. Nevertheless, quality alone does not guarantee safety or efficacy in humans if the product is not proven to work or if there are material risks.

Option 4: 'All of the above.' When considering a new vaccine, regulators examine safety, efficacy, and quality collectively. The regulatory approval process integrates all three domains to ensure a vaccine is safe, effective, and manufactured to high quality standards before it reaches the market.

Rationale for why each choice may be considered insufficient on its own: Safety alone cannot confirm that the vaccine prevents disease or that the manufacturing process yields a reliable product. Efficacy without assurance of consistent quality could lead to variable or unethical outcomes. Quality without evidence of regulatory safety and efficacy would not provide a complete guarantee for public health. Thus, the most comprehensive and accurate choice reflects the integrated regulatory assessment across all three areas.

In sum, the statement that encompasses all essential regulatory considerations—safety, efficacy, and quality—best captures the rigorous evaluation performed before vaccine approval, illustrating why a combined approach is required in regulatory review.

Before a new vaccine is approved for release on the market, a rigorous regulatory procedure to assess these steps should be undertaken: 单项选择题

类似问题

Question at position 52 When the FDA considers a new vaccine for approval their two main concerns are…Safety and efficacyFast approval and costProfit and lossNone of the aboveClear my selection

In which security measure will you find anti-virus software?

What are user permissions?

Which security measure will stop someone reading your messages if they find your smart phone?

On a network a firewall

What is the name for emails that are sent to users, pretending to be from their bank and asking for username and password?

To stop users of a network from playing games all day instead of working, which would be the best security measure to use?

Which of the following security threats is the cause of the greatest amount of data loss?

更多留学生实用工具

智能学习助手

风格化写作助手

论文查重助手

文献引用助手

课堂转译助手

课堂笔记助手

Quiz搜索助手

学校历年真题

智能刷题助手

智能匹配练习

希望你的学习变得更简单